Rare success for Alzheimer's research unlocks hope for future therapies
Drugmakers Eisai and Biogen reported in September that their therapy lecanemab could slow progress of the disease by 27%
0
Drugmakers Eisai and Biogen reported in September that their therapy lecanemab could slow progress of the disease by 27%
0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.